Milica Bugarski1, Susan Ghazi1, Marcello Polesel1, Joana R Martins1,2, Andrew M Hall3,4. 1. Institute of Anatomy, University of Zurich, Zurich, Switzerland. 2. Center for Microscopy and Image Analysis, University of Zurich, Zurich, Switzerland. 3. Institute of Anatomy, University of Zurich, Zurich, Switzerland andrew.hall@uzh.ch. 4. Department of Nephrology, University Hospital Zurich, Zurich, Switzerland.
Abstract
BACKGROUND: The kidney plays an important role in maintaining normal blood pH. Metabolic acidosis (MA) upregulates the pathway that mitochondria in the proximal tubule (PT) use to produce ammonia and bicarbonate from glutamine, and is associated with AKI. However, the extent to which MA causes AKI, and thus whether treating MA would be beneficial, is unclear. METHODS: Gavage with ammonium chloride induced acute MA. Multiphoton imaging of mitochondria (NADH/membrane potential) and transport function (dextran/albumin uptake), oxygen consumption rate (OCR) measurements in isolated tubules, histologic analysis, and electron microscopy in fixed tissue, and urinary biomarkers (KIM-1/clara cell 16) assessed tubular cell structure and function in mouse kidney cortex. RESULTS: MA induces an acute change in NAD redox state (toward oxidation) in PT mitochondria, without changing the mitochondrial energization state. This change is associated with a switch toward complex I activity and decreased maximal OCR, and a major alteration in normal lipid metabolism, resulting in marked lipid accumulation in PTs and the formation of large multilamellar bodies. These changes, in turn, lead to acute tubular damage and a severe defect in solute uptake. Increasing blood pH with intravenous bicarbonate substantially improves tubular function, whereas preinjection with the NAD precursor nicotinamide (NAM) is highly protective. CONCLUSIONS: MA induces AKI via changes in PT NAD and lipid metabolism, which can be reversed or prevented by treatment strategies that are viable in humans. These findings might also help to explain why MA accelerates decline in function in CKD.
BACKGROUND: The kidney plays an important role in maintaining normal blood pH. Metabolic acidosis (MA) upregulates the pathway that mitochondria in the proximal tubule (PT) use to produce ammonia and bicarbonate from glutamine, and is associated with AKI. However, the extent to which MA causes AKI, and thus whether treating MA would be beneficial, is unclear. METHODS: Gavage with ammonium chloride induced acute MA. Multiphoton imaging of mitochondria (NADH/membrane potential) and transport function (dextran/albumin uptake), oxygen consumption rate (OCR) measurements in isolated tubules, histologic analysis, and electron microscopy in fixed tissue, and urinary biomarkers (KIM-1/clara cell 16) assessed tubular cell structure and function in mouse kidney cortex. RESULTS: MA induces an acute change in NAD redox state (toward oxidation) in PT mitochondria, without changing the mitochondrial energization state. This change is associated with a switch toward complex I activity and decreased maximal OCR, and a major alteration in normal lipid metabolism, resulting in marked lipid accumulation in PTs and the formation of large multilamellar bodies. These changes, in turn, lead to acute tubular damage and a severe defect in solute uptake. Increasing blood pH with intravenous bicarbonate substantially improves tubular function, whereas preinjection with the NAD precursor nicotinamide (NAM) is highly protective. CONCLUSIONS: MA induces AKI via changes in PT NAD and lipid metabolism, which can be reversed or prevented by treatment strategies that are viable in humans. These findings might also help to explain why MA accelerates decline in function in CKD.
Authors: Tsz-Leung To; Alejandro M Cuadros; Hardik Shah; Wendy H W Hung; Yang Li; Sharon H Kim; Daniel H F Rubin; Ryan H Boe; Sneha Rath; John K Eaton; Federica Piccioni; Amy Goodale; Zohra Kalani; John G Doench; David E Root; Stuart L Schreiber; Scott B Vafai; Vamsi K Mootha Journal: Cell Date: 2019-11-14 Impact factor: 41.582
Authors: R A Giuliano; G J Paulus; G A Verpooten; V M Pattyn; D E Pollet; E J Nouwen; G Laurent; M B Carlier; P Maldague; P M Tulkens Journal: Kidney Int Date: 1984-12 Impact factor: 10.612
Authors: Adam Lister; Soline Bourgeois; Pedro H Imenez Silva; Isabel Rubio-Aliaga; Philippe Marbet; Joanne Walsh; Luke M Shelton; Bettina Keller; Francois Verrey; Olivier Devuyst; Pieter Giesbertz; Hannelore Daniel; Christopher E Goldring; Ian M Copple; Carsten A Wagner; Alex Odermatt Journal: Sci Rep Date: 2018-04-04 Impact factor: 4.379
Authors: Martin Gritter; Rosa D Wouda; Stanley M H Yeung; Michiel L A Wieërs; Frank Geurts; Maria A J de Ridder; Christian R B Ramakers; Liffert Vogt; Martin H de Borst; Joris I Rotmans; Ewout J Hoorn Journal: J Am Soc Nephrol Date: 2022-05-24 Impact factor: 14.978
Authors: Marta Figueiredo; Arezoo Daryadel; Gabin Sihn; Dominik N Müller; Elena Popova; Anthony Rouselle; Genevieve Nguyen; Michael Bader; Carsten A Wagner Journal: Pflugers Arch Date: 2021-07-06 Impact factor: 3.657